Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-26
2007-06-26
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017400, C530S300000, C530S329000
Reexamination Certificate
active
11030794
ABSTRACT:
A method for managing withdrawal from an addictive substance is described. The method involves administering one or more peptides having specific activity for the ε and/or γ isozyme of protein kinase C (PKC). The peptide(s) can be administered prior to, concurrent with, or subsequent to administration of the addictive substance. Also described is a kit having at least one container containing a peptide having isozyme-specific activity for εPKC or γPKC and instructions for use.
REFERENCES:
patent: 5783405 (1998-07-01), Mochly-Rosen et al.
patent: 5846974 (1998-12-01), Kallman et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6180620 (2001-01-01), Salvemini
patent: 6376467 (2002-04-01), Messing et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6686334 (2004-02-01), Messing et al.
patent: 6933275 (2005-08-01), Mochly-Rosen et al.
patent: 2002/0124272 (2002-09-01), Messing et al.
patent: 2003/0166037 (2003-09-01), Fourie et al.
patent: 2003/0223981 (2003-12-01), Mochly-Rosen et al.
patent: WO 00/01805 (2000-01-01), None
patent: WO 03/089457 (2003-10-01), None
Mitchell et al. Polyarginine enters cells more efficiently than other polycationic homopolymers. Journal of Peptide Research. 2000, vol. 56, pp. 318-325.
Schwarze et al. In Vivo Protein Transduction. . . Science. Sep. 3, 1999, vol. 285, pp. 1569-1572.
Aley, K. O., et al.,The Journal of Neuroscience, 20(12):4680-4685, (2000).
Dina, O.A., et al.,The Journal of Neuroscience20(22):8614-8619, (2000).
Narita, M., et al.,The Journal of Neuroscience21(11):3715-3720, (2001).
Johnson, J.A., et al.,The Journal of Biological Chemistry, 271(40):24962-24966, (1996).
Kendig Joan J.
Mochly-Rosen Daria
Sweitzer Sarah M.
Mohr Judy M.
Perkins Coie LLP
Russel Jeffrey Edwin
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Protein kinase C peptides for use in withdrawal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase C peptides for use in withdrawal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C peptides for use in withdrawal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3824423